 - Participants with clinically stable medical condition, consistent with ESRD, as judged by the investigator on the basis of the Screening physical examination, medical history, vital signs, 12-lead electrocardiogram ECG, and results of clinical laboratory tests performed within 3 weeks of the first administration of study drug unless judged to be clinically unimportant by the investigator or sponsor 